The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
A Study of the ReCor Medical Paradise System in Stage II Hypertension (High Blood Pressure)
Sponsor: ReCor Medical, Inc.
Enrolling: Male and Female Patients
Study Length: 3 Years
Clinic Visits: 10
IRB Number: AAAS0371
U.S. Govt. ID: NCT03614260
Contact: Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu
Additional Study Information: RADIANCE II is a randomized, double-blind, sham-controlled, single cohort study designed todemonstrate the effectiveness (how well it works) and safety of the Paradise Renal Denervation System in hypertensive subjects (subjects with high blood pressure).
This study is closed
Investigator
Ajay Kirtane, MD, SM
Do You Qualify?
Is your blood pressure 140/90 or more? Yes No
Previously or currently prescribed antihypertensive therapy? Yes No
Do you have a diagnosis of Type 1 Diabetes? Yes No
Do you work night shift? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Kate Dalton
keb2114@cumc.columbia.edu
347-514-3366
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE